Icecure Medical Share Price (NASDAQ: ICCM)

$0.88

Last updated on August 23, 2025 at 1:29 AM IST

$₹

Check the interactive Icecure Medical Stock chart to analyse performance

Icecure Medical stock performance

as on August 23, 2025 at 1:29 AM IST

Today's Low:$0.86
Today's High:$0.89
$0.88
2.27%
Downside
Day's Volatility :3.09%
Upside
0.83%
52 Weeks Low:$0.48
52 Weeks High:$1.66
$0.88
45.45%
Downside
52 Weeks Volatility :71.08%
Upside
46.99%

Icecure Medical Stock Returns

Period	Icecure Medical Ltd	Index (Russel 2000)
3 Months	-21.47%	0.0%
6 Months	-37.06%	0.0%
1 Year	28.61%	0.0%
3 Years	-49.36%	-8.6%

Icecure Medical Ltd Key Stats

Check Icecure Medical key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.88
Open	$0.87
Today's High	$0.8874
Today's Low	$0.86
Market Capitalization	$60.1M
Today's Volume	$364.2K
52 Week High	$1.66
52 Week Low	$0.48
Revenue TTM	$2.8M
EBITDA	$-15.5M
Earnings Per Share (EPS)	$-0.27
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-230.8%

Stock Returns calculator for Icecure Medical Stock including INR - Dollar returns

The Icecure Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Icecure Medical investment value today

Current value as on today

₹1,31,852

Returns

₹31,852

(+31.85%)

Returns from Icecure Medical Stock

₹27,536 (+27.54%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Icecure Medical Stock

280%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Icecure Medical Stock from India on INDmoney has increased by 280% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Icecure Medical Ltd

Name
Holdings %
Name
Holdings %
Geode Capital Management, LLC
0.07%
XTX Topco Ltd
0.04%
LPL Financial Corp
0.03%
Foundations Investment Advisors, LLC
0.03%
Janney Montgomery Scott LLC
0.02%
JPMorgan Chase & Co
0.01%

Analyst Recommendation on Icecure Medical Stock

Rating

Trend

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Icecure Medical(by analysts ranked 0 to 5 stars)

Icecure Medical Share Price Target

What analysts predicted

Upside of 194.32%

Target:

$2.59

Current:

$0.88

Icecure Medical share price target is $2.59, a slight Upside of 194.32% compared to current price of $0.88 as per analysts' prediction.

Icecure Medical Stock Insights

Price Movement
In the last 3 months, ICCM stock has moved down by -16.3%
Decreasing Revenue
Revenue is down for the last 3 quarters, 875.0K → 525.0K (in $), with an average decrease of 22.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -4.47M → -3.36M (in $), with an average increase of 15.8% per quarter
ICCM vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 34.1% return, outperforming this stock by 10.4%
ICCM vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 158.0% return, outperforming this stock by 208.4%
Price to Sales
ForICCM every $1 of sales, investors are willing to pay $17.7, whereas for Boston Scientific Corp., the investors are paying $8.5 for every $1 of sales.

Icecure Medical Ltd Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.7M	↑ 54.64%
Net Income	$-4.8M	↑ 34.7%
Net Profit Margin	-287.18%	↑ 42.52%

	FY20	Y/Y Change
Revenue	$4.1M	↑ 146.41%
Net Income	$-4.8M	↑ 0.35%
Net Profit Margin	-116.96%	↑ 170.22%

	FY21	Y/Y Change
Revenue	$4.1M	↑ 1.31%
Net Income	$-10.1M	↑ 110.71%
Net Profit Margin	-243.26%	↓ 126.3%

	FY22	Y/Y Change
Revenue	$3.1M	↓ 25.45%
Net Income	$-17.2M	↑ 71.04%
Net Profit Margin	-558.09%	↓ 314.83%

	FY23	Y/Y Change
Revenue	$3.2M	↑ 4.67%
Net Income	$-14.7M	↓ 14.9%
Net Profit Margin	-453.76%	↑ 104.33%

	FY24	Y/Y Change
Revenue	$3.3M	↑ 1.92%
Net Income	$-15.3M	↑ 4.55%
Net Profit Margin	-465.45%	↓ 11.69%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$736.4K	↓ 41.33%
Net Income	$-3.6M	↑ 19.42%
Net Profit Margin	-485.73%	↓ 247.08%

	Q2 FY24	Q/Q Change
Revenue	$1.0M	↑ 37.3%
Net Income	$-3.1M	↓ 13.86%
Net Profit Margin	-304.75%	↑ 180.98%

	Q3 FY24	Q/Q Change
Revenue	$662.0K	↓ 34.52%
Net Income	$-4.1M	↑ 34.66%
Net Profit Margin	-626.74%	↓ 321.99%

	Q4 FY24	Q/Q Change
Revenue	$875.0K	↑ 32.18%
Net Income	$-4.5M	↑ 7.95%
Net Profit Margin	-511.89%	↑ 114.85%

	Q1 FY25	Q/Q Change
Revenue	$725.0K	↓ 17.14%
Net Income	$-3.6M	↓ 19.89%
Net Profit Margin	-494.9%	↑ 16.99%

	Q2 FY25	Q/Q Change
Revenue	$525.0K	↓ 27.59%
Net Income	$-3.4M	↓ 6.24%
Net Profit Margin	-640.76%	↓ 145.86%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$576.4K	↑ 28.45%

	FY20	Y/Y Change
Profit	$2.7M	↑ 361.19%

	FY21	Y/Y Change
Profit	$2.2M	↓ 17.43%

	FY22	Y/Y Change
Profit	$1.4M	↓ 34.17%

	FY23	Y/Y Change
Profit	$1.3M	↓ 10.03%

	FY24	Y/Y Change
Profit	$1.5M	↑ 11.62%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$266.6K	↓ 53.15%

	Q2 FY24	Q/Q Change
Profit	$530.0K	↑ 98.8%

	Q3 FY24	Q/Q Change
Profit	$235.0K	↓ 55.66%

	Q4 FY24	Q/Q Change
Profit	$417.0K	↑ 77.45%

	Q1 FY25	Q/Q Change
Profit	$218.0K	↓ 47.72%

	Q2 FY25	Q/Q Change
Profit	$131.0K	↓ 39.91%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-1.7M	↓ 43.14%
Investing Cash Flow	$-102.2K	↑ 59.1%
Financing Cash Flow	$3.1M	↓ 48.8%

	FY20	Y/Y Change
Operating Cash Flow	$-3.7M	↑ 113.43%
Investing Cash Flow	$-4.9M	↑ 4710.42%
Financing Cash Flow	$5.9M	↑ 94.09%

	FY21	Y/Y Change
Operating Cash Flow	$-12.6M	↑ 239.04%
Investing Cash Flow	$3.8M	↓ 177.11%
Financing Cash Flow	$30.9M	↑ 419.46%

	FY22	Y/Y Change
Operating Cash Flow	$-14.3M	↑ 13.38%
Investing Cash Flow	$-891.0K	↓ 123.5%
Financing Cash Flow	$13.6M	↓ 56.05%

	FY23	Y/Y Change
Operating Cash Flow	$-12.5M	↓ 12.39%
Investing Cash Flow	$-713.0K	↓ 19.98%
Financing Cash Flow	$83.0K	↓ 99.39%

	FY24	Y/Y Change
Operating Cash Flow	$-12.6M	↑ 0.34%
Investing Cash Flow	$446.0K	↓ 162.55%
Financing Cash Flow	$9.2M	↑ 10968.67%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-2.8M	↑ 6.9%
Investing Cash Flow	$486.6K	-
Financing Cash Flow	$2.8M	↑ 4034.72%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-2.4M	↓ 16.4%
Investing Cash Flow	$-843.0K	↓ 273.24%
Financing Cash Flow	$1.9M	↓ 32.78%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-3.2M	↑ 33.43%
Investing Cash Flow	$805.0K	↓ 195.49%
Financing Cash Flow	$3.4M	↑ 77.72%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-4.2M	↑ 33.05%
Investing Cash Flow	$-7.0K	↓ 100.87%
Financing Cash Flow	$1.1M	↓ 67.22%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-4.0M	↓ 3.72%
Investing Cash Flow	$-5.0K	↓ 28.57%
Financing Cash Flow	$2.6M	↑ 132.7%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-2.8M	↓ 30.4%
Investing Cash Flow	$-23.0K	↑ 360.0%
Financing Cash Flow	$2.1M	↓ 18.62%

Icecure Medical Technicals Summary

Sell

Neutral

Buy

Icecure Medical is currently in a neutral trading position according to technical analysis indicators.

Icecure Medical Ltd Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Icecure Medical Ltd	-17.07%	-37.06%	28.61%	-49.36%	-91.86%
Medtronic Plc	-0.24%	2.83%	3.78%	0.63%	-9.62%
Edwards Lifesciences Corp.	2.2%	12.37%	18.92%	-15.41%	1.75%
Boston Scientific Corp.	0.01%	1.69%	33.57%	154.07%	167.79%
Stryker Corporation	-2.33%	1.6%	11.24%	81.88%	107.9%
Abbott Laboratories	4.76%	-1.77%	17.62%	25.19%	29.36%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Icecure Medical Ltd	NA	NA	NA	-0.22	-2.31	-0.76	NA	0.05
Medtronic Plc	25.17	25.17	2.19	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	33.96	33.96	4.86	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.63	62.63	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.04	51.04	2.23	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.56	16.56	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Icecure Medical Ltd	Buy	$60.1M	-91.86%	NA	0.0%
Medtronic Plc	Buy	$116.7B	-9.62%	25.17	13.63%
Edwards Lifesciences Corp.	Buy	$47.6B	1.75%	33.96	72.96%
Boston Scientific Corp.	Buy	$155.9B	167.79%	62.63	13.55%
Stryker Corporation	Buy	$147.1B	107.9%	51.04	12.25%
Abbott Laboratories	Buy	$229.7B	29.36%	16.56	32.43%

About Icecure Medical Ltd

IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Organization	Icecure Medical
Employees	64
CEO	Mr. Eyal Shamir
Industry	Miscellaneous

Key Management of Icecure Medical Ltd

Name	Title
Mr. Eyal Shamir	CEO & Director
Mr. Ronen Tsimerman CPA	CFO & COO
Ms. Tlalit Bussi Tel-Tzure	Vice President of Business Development & Global Marketing
Mr. Shad Good	Vice President of Sales for North America
Ms. Merav Nir Dotan	Vice President of Human Resources
Ms. Galit Malik	Vice President of Operations & Service

Important FAQs about investing in ICCM Stock from India :

What is Icecure Medical share price today?

Icecure Medical share price today is $0.88 as on August 23, 2025 at 1:29 AM IST at the close of the market. Icecure Medical share today touched a day high of $0.89 and a low of $0.86.

What is the 52 week high and 52 week low for Icecure Medical share?

Icecure Medical share touched a 52 week high of $1.66 and a 52 week low of $0.48. Icecure Medical stock price today i.e. August 23, 2025 at 1:29 AM IST is closed at $0.88, lower by 46.99% versus the 52 week high.

How to invest in Icecure Medical Stock (ICCM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Icecure Medical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Icecure Medical Shares that will get you 1.7045 shares as per Icecure Medical share price of $0.88 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Icecure Medical Stock (ICCM) from India?

Indian investors can start investing in Icecure Medical (ICCM) shares with as little as ₹87.521 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Icecure Medical stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Icecure Medical share’s latest price of $0.88 as on August 23, 2025 at 1:29 AM IST, you will get 11.3636 shares of Icecure Medical. Learn more about fractional shares .

What are the returns that Icecure Medical has given to Indian investors in the last 5 years?

Icecure Medical stock has given -91.86% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?